Actively Recruiting
Study of a Shared Decision-Making Model to Help Adults with Autosomal Dominant Polycystic Kidney Disease Choose Tolvaptan Treatment
Led by Seoul National University Hospital · Updated on 2024-11-07
340
Participants Needed
9
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a shared decision-making model to help patients with autosomal dominant polycystic kidney disease ADPKD decide whether to use the drug tolvaptan. This study aims to create and test this model, which supports patients by providing information and tools to consider personal values, potential side effects, and lifestyle factors related to tolvaptan treatment. The trial is designed as a multi-center randomized controlled study to assess how well this approach works and if it is feasible for patients. The shared decision-making model includes a mobile application offering patient education, decision aids, and self-monitoring tools based on the SHARE approach. Participants are randomly assigned to either the group using the shared decision-making model or to receive usual care without this support. This behavioral intervention focuses on improving treatment decisions through enhanced patient engagement and information sharing. Participants aged 18 to 80 with certain stages of chronic kidney disease CKD and ADPKD classification will be involved. They must be able to communicate and use digital devices without severe vision or cognitive problems. Researchers will measure changes in kidney volume over 12 months and assess treatment outcomes, patient satisfaction, adherence, and quality of life. The study will last at least one year and includes close monitoring of participants progress and experiences.
CONDITIONS
Brief Title
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
Research Team
J
Jisun Chun
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here